Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.720
-0.010 (-0.58%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Imunon Employees
Imunon had 20 employees as of December 31, 2025. The number of employees decreased by 5 or -20.00% compared to the previous year.
Employees
20
Change (1Y)
-5
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$732,078
Market Cap
7.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 20 | -5 | -20.00% |
| Dec 31, 2024 | 25 | -8 | -24.24% |
| Dec 31, 2023 | 33 | 2 | 6.45% |
| Dec 31, 2022 | 31 | 2 | 6.90% |
| Dec 31, 2021 | 29 | 2 | 7.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| NuCana | 12 |
| MetaVia | 8 |
| Immuron | 7 |
| Can-Fite BioPharma | 5 |
| Creative Medical Technology Holdings | 4 |
IMNN News
- 21 hours ago - Imunon Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 21 hours ago - Imunon Slides: Life Sciences Virtual Investor Forum - Filings
- 3 days ago - Imunon announces IDMC recommendation for continuation of OVATION 3 trial - TheFly
- 3 days ago - IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification - GlobeNewsWire
- 3 days ago - IMUNON to Present at the Life Sciences Investor Forum on June 25th - GlobeNewsWire
- 9 days ago - Imunon Transcript: AGM 2026 - Transcripts
- 22 days ago - IMUNON Announces Up to $10 Million Cash Financing - GlobeNewsWire
- 6 weeks ago - Imunon reports Q1 EPS (84c), consensus ($1.28) - TheFly